Windtree Therapeutics Stock Technical Analysis
| WINT Stock | USD 0.02 0 15.00% |
As of the 30th of January, Windtree Therapeutics maintains the Standard Deviation of 9.88, mean deviation of 6.62, and Market Risk Adjusted Performance of (2.16). Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Windtree Therapeutics, as well as the relationship between them.
Windtree Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Windtree, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to WindtreeWindtree Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Windtree Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 4.0 | Hold | 1 | Odds |
Most Windtree analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Windtree stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Windtree Therapeutics, talking to its executives and customers, or listening to Windtree conference calls.
Is there potential for Biotechnology market expansion? Will Windtree introduce new products? Factors like these will boost the valuation of Windtree Therapeutics. Anticipated expansion of Windtree directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Windtree Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Understanding Windtree Therapeutics requires distinguishing between market price and book value, where the latter reflects Windtree's accounting equity. The concept of intrinsic value—what Windtree Therapeutics' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Windtree Therapeutics' price substantially above or below its fundamental value.
Please note, there is a significant difference between Windtree Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Windtree Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Windtree Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Windtree Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Windtree Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Windtree Therapeutics.
| 11/01/2025 |
| 01/30/2026 |
If you would invest 0.00 in Windtree Therapeutics on November 1, 2025 and sell it all today you would earn a total of 0.00 from holding Windtree Therapeutics or generate 0.0% return on investment in Windtree Therapeutics over 90 days. Windtree Therapeutics is related to or competes with Revelation Biosciences, Dermata Therapeutics, Avenue Therapeutics, XORTX Therapeutics, Virax Biolabs, Ainos, and NewcelX. Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for ... More
Windtree Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Windtree Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Windtree Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.25) | |||
| Maximum Drawdown | 58.33 | |||
| Value At Risk | (20.00) | |||
| Potential Upside | 16.67 |
Windtree Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Windtree Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Windtree Therapeutics' standard deviation. In reality, there are many statistical measures that can use Windtree Therapeutics historical prices to predict the future Windtree Therapeutics' volatility.| Risk Adjusted Performance | (0.17) | |||
| Jensen Alpha | (2.47) | |||
| Total Risk Alpha | (3.11) | |||
| Treynor Ratio | (2.17) |
Windtree Therapeutics January 30, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.17) | |||
| Market Risk Adjusted Performance | (2.16) | |||
| Mean Deviation | 6.62 | |||
| Coefficient Of Variation | (410.70) | |||
| Standard Deviation | 9.88 | |||
| Variance | 97.56 | |||
| Information Ratio | (0.25) | |||
| Jensen Alpha | (2.47) | |||
| Total Risk Alpha | (3.11) | |||
| Treynor Ratio | (2.17) | |||
| Maximum Drawdown | 58.33 | |||
| Value At Risk | (20.00) | |||
| Potential Upside | 16.67 | |||
| Skewness | (0.28) | |||
| Kurtosis | 2.01 |
Windtree Therapeutics Backtested Returns
Windtree Therapeutics shows Sharpe Ratio of -0.22, which attests that the company had a -0.22 % return per unit of risk over the last 3 months. Windtree Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Windtree Therapeutics' Standard Deviation of 9.88, mean deviation of 6.62, and Market Risk Adjusted Performance of (2.16) to validate the risk estimate we provide. The firm maintains a market beta of 1.11, which attests to a somewhat significant risk relative to the market. Windtree Therapeutics returns are very sensitive to returns on the market. As the market goes up or down, Windtree Therapeutics is expected to follow. At this point, Windtree Therapeutics has a negative expected return of -2.2%. Please make sure to check out Windtree Therapeutics' treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and period momentum indicator , to decide if Windtree Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.79 |
Good predictability
Windtree Therapeutics has good predictability. Overlapping area represents the amount of predictability between Windtree Therapeutics time series from 1st of November 2025 to 16th of December 2025 and 16th of December 2025 to 30th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Windtree Therapeutics price movement. The serial correlation of 0.79 indicates that around 79.0% of current Windtree Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.79 | |
| Spearman Rank Test | 0.3 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Windtree Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Windtree Therapeutics Technical Analysis
Indicator |
The output start index for this execution was one with a total number of output elements of sixty. The True Range is a measure of Windtree Therapeutics volatility developed by Welles Wilder.
About Windtree Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Windtree Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Windtree Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Windtree Therapeutics price pattern first instead of the macroeconomic environment surrounding Windtree Therapeutics. By analyzing Windtree Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Windtree Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Windtree Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Dividend Yield | 0.64 | 0.58 | Price To Sales Ratio | 633.33 | 664.99 |
Windtree Therapeutics January 30, 2026 Technical Indicators
Most technical analysis of Windtree help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Windtree from various momentum indicators to cycle indicators. When you analyze Windtree charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.17) | |||
| Market Risk Adjusted Performance | (2.16) | |||
| Mean Deviation | 6.62 | |||
| Coefficient Of Variation | (410.70) | |||
| Standard Deviation | 9.88 | |||
| Variance | 97.56 | |||
| Information Ratio | (0.25) | |||
| Jensen Alpha | (2.47) | |||
| Total Risk Alpha | (3.11) | |||
| Treynor Ratio | (2.17) | |||
| Maximum Drawdown | 58.33 | |||
| Value At Risk | (20.00) | |||
| Potential Upside | 16.67 | |||
| Skewness | (0.28) | |||
| Kurtosis | 2.01 |
Windtree Therapeutics January 30, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Windtree stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 176,356 | ||
| Daily Balance Of Power | (0.83) | ||
| Rate Of Daily Change | 0.85 | ||
| Day Median Price | 0.02 | ||
| Day Typical Price | 0.02 | ||
| Price Action Indicator | 0.00 |
Additional Tools for Windtree Stock Analysis
When running Windtree Therapeutics' price analysis, check to measure Windtree Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Windtree Therapeutics is operating at the current time. Most of Windtree Therapeutics' value examination focuses on studying past and present price action to predict the probability of Windtree Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Windtree Therapeutics' price. Additionally, you may evaluate how the addition of Windtree Therapeutics to your portfolios can decrease your overall portfolio volatility.